The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae
Open accessAbstract
Broth microdilution MICs were determined for 258 clinical isolates of Mycobacterium fortuitum (3 biovariants) and M. chelonae (2 subspecies) with amikacin, tobramycin, cefoxitin, doxycycline, erythromycin, and sulfamethoxazole-trimethoprim and with several new beta-lactams and aminoglycosides and ciprofloxacin. Variations in susceptibility by and within species subgroups confirm the need for susceptibility testing against clinically important strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Spectrum of Disease Due to Rapidly Growing Mycobacteria
Wallace, R. J., Swenson, J. M., Silcox, V. A., Good, R. C., Tschen, J. A., & Stone, M. S. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.4.657 · Cited by 584
Self-citationWallace, R. J., Swenson, J. M., Silcox, V. A., & Bullen, M. G. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/152.3.500 · Cited by 272
Self-citationSwenson, J. M., Thornsberry, C., & Silcox, V. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.2.186 · Cited by 187
Self-citationIdentification of clinically significant Mycobacterium fortuitum complex isolates
Silcox, V. A., Good, R. C., & Floyd, M. M. (1981) · Journal of Clinical Microbiology · doi:10.1128/jcm.14.6.686-691.1981 · Cited by 172
Self-citationDalovisio, J. R., Pankey, G. A., Wallace, R. J., & Jones, D. B. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.5.1068 · Cited by 122
Self-citationWallace, R. J., Dalovisio, J. R., & Pankey, G. A. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.5.611 · Cited by 120
Self-citationStone, M. S., Wallace, R. J., Swenson, J. M., Thornsberry, C., & Christensen, L. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.4.486 · Cited by 62
Self-citationIdentification of Mycobacterium fortuitum and Mycobacterium chelonei
Lévy‐Frébault, V., Daffé, M., Goh, K. S., Lanéelle, M., Asselineau, C., & David, H. L. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.17.5.744-752.1983 · Cited by 42
Cynamon, M. H., & Palmer, G. S. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.6.935 · Cited by 16
Cited by
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationKrause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Epidemiology of infection by nontuberculous mycobacteria
Falkinham, J. O. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.177 · Cited by 1,113
Brown-Elliott, B. A., & Wallace, R. J. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.716-746.2002 · Cited by 909
Self-citationDiagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
Wallace, R. J., O'Brien, R., Glassroth, J., Raleigh, J., & Dutt, A. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.4.940 · Cited by 894
Self-citationDiagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
(1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.atsstatement · Cited by 790
Campoli-Richards, D. M., Monk, J. P., Price, A., Benfield, P., Todd, P. A., & Ward, A. (1988) · Drugs · doi:10.2165/00003495-198835040-00003 · Cited by 749
Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s
Tortoli, E. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.319-354.2003 · Cited by 574
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Self-citationGriffith, D. E., Girard, W. M., & Wallace, R. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1271 · Cited by 518
Self-citationAdekambi, T. (2006) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.63969-0 · Cited by 366
Wallace, R. J., Brown, B. A., & Onyi, G. O. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.2.405 · Cited by 361
Self-citationResistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
van Ingen, J., Boeree, M. J., van Soolingen, D., & Mouton, J. W. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.04.001 · Cited by 351
Permeability barrier to hydrophilic solutes in Mycobacterium chelonei
Jarlier, V, & Nikaido, H. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.3.1418-1423.1990 · Cited by 315
Brown, B. A., Wallace, R. J., Onyi, G. O., De Rosas, V, & Wallace, R. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.180 · Cited by 301
Self-citationAdékambi, T., Reynaud-Gaubert, M., Greub, G., Gevaudan, M.-J., La Scola, B., Raoult, D., & Drancourt, M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5493-5501.2004 · Cited by 299
Doucette, K., & Fishman, J. A. (2004) · Clinical Infectious Diseases · doi:10.1086/420746 · Cited by 287
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Self-citationSafranek, T. J., Jarvis, W. R., Carson, L. A., Cusick, L. B., Bland, L. A., Swenson, J. M., & Silcox, V. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170403 · Cited by 270
Self-citation
Metadata
- Authors
- Swenson, J. M., Wallace, R. J., Silcox, V. A., & Thornsberry, C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1985-12
- Volume
- 28
- Issue
- 6
- Pages
- 807-811
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2123352640
- Cited by
- 258
- References
- 10
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.